Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma: Results of the Proof-of-Concept iMYC Study.
Turkes F, Bryant A, Begum R, Davidson M, Kalaitzaki E, Aresu M, Lazaro-Alcausi R, Bryant J, Rana I, Chua S, Aronson L, Hulkki-Wilson S, Fribbens C, Watkins D, Rao S, Starling N, Cunningham D, Chong IY, Chau I.
Turkes F, et al. Among authors: kalaitzaki e.
Curr Oncol. 2022 Mar 22;29(4):2174-2184. doi: 10.3390/curroncol29040176.
Curr Oncol. 2022.
PMID: 35448150
Free PMC article.